TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ABVX

Abivax S.A.

Healthcare · Biotechnology

103.50$ -1.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

Abivax S.A. (ABVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 547 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABVX
Line item Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
76 171 327 284 205 167 120 652 652 547
36 36 130 130 286 243 171 133 86 619 619 513
27 114 252 222 144 104 61 590 516 477
27 114 261 222 144 61 530
8.3 8.3 13 13 19 18 16 15 10
12 3.0 -5.9
1.6 1.6 1.4 1.4
18 18 18 18 18 18 18 18 18 18
6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6 6.6
68 91 131 158 165 174 168 141 141 118
32 51 46 46 88 80 93 106 112 79 79 62
30 9.7 31 38 44 49 29
15 15 29 15 47 31 44 57 36 14 38 10.0
37 24 45 52 47 35 16
7.2 80 196 126 41 -6.6 -48 511 455 430
-61 -144 -195 -52 -283 -353 -439 -487 -529 -670 -738 -764
22 36 48 63 63 63 63 78 70 79

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?